ADAPTIVE BIOTECHNOLOGIES CORPORATION Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2015-05-11: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-05-05; Total offering amount $195,099,954.
- 2015-01-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-01-07; Total offering amount $93,750,000.
- 2015-01-21: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-01-07; Total offering amount $95,716,444.
- 2014-08-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-04-04; Total offering amount $106,999,480.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2015-05-11 | Rule 506(b) | Equity | 2015-05-05 | $195,099,954 | $195,099,954 | $0 | 16 |
| 2015-01-22 | Rule 506(b) | Equity | 2015-01-07 | $93,750,000 | $93,750,000 | $0 | 4 |
| 2015-01-21 | Rule 506(b) | Equity | 2015-01-07 | $95,716,444 | $95,716,444 | $0 | 61 |
| 2014-08-04 D/A | Rule 506(b) | Equity | 2014-04-04 | $106,999,480 | $106,999,480 | $0 | 6 |
| 2014-04-15 | Rule 506(b) | Equity | 2014-04-04 | $104,999,480 | $104,999,480 | $0 | 4 |
| 2013-07-12 | Rule 506 | Equity | 2013-07-01 | $19,999,997 | $5,024,792 | $14,975,205 | 3 |
| 2012-06-21 | Rule 506 | Equity | 2012-06-07 | $5,048,707 | $2,649,272 | $2,399,435 | 37 |
| 2011-06-02 | Rule 506 | Equity | 2011-05-20 | $7,500,000 | $5,821,524 | $1,678,476 | 63 |
| 2009-12-28 | Rule 506 | Equity | 2009-12-17 | $5,000,000 | $3,955,000 | $1,045,000 | 50 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |